<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To investigate the incidence, characteristics, and prognostic impact of prior extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> on patients with <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> (<z:mp ids='MP_0009151'>PDAC</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Records from 1733 patients who underwent surgery for <z:mp ids='MP_0009151'>PDAC</z:mp> were analyzed for the occurrence of prior extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients' records showing extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> were then analyzed for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type, epidemiological data, risk factors, <z:mp ids='MP_0009151'>PDAC</z:mp> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage, and long-term survival </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A total of 239 patients with <z:mp ids='MP_0009151'>PDAC</z:mp> (13.8%) had a history of 271 extrapancreatic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; 26 patients had a history of two <z:hpo ids='HP_0002894'>pancreatic cancers</z:hpo>, and 3 patients had 3 extrapancreatic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The most common extrapancreatic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (56 patients) and <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> (41 patients), followed by colorectal, reno/urothelial, and <z:e sem="disease" ids="C0017416" disease_type="Neoplastic Process" abbrv="">gynecologic tumors</z:e> (39, 32, and 23 patients, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>No significant difference in overall survival was found between patients with <z:mp ids='MP_0009151'>PDAC</z:mp> with or without extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0002894'>Pancreatic cancer</z:hpo> is associated with extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in a remarkable number of patients </plain></SENT>
<SENT sid="7" pm="."><plain>A history of extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> does not influence prognosis and should not be an obstacle to a curative therapeutic approach </plain></SENT>
<SENT sid="8" pm="."><plain>Surveillance of patients with extrapancreatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, especially breast, prostate, and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, could allow for earlier <z:mp ids='MP_0009151'>PDAC</z:mp> diagnosis and therefore improve prognosis of these patients </plain></SENT>
</text></document>